Drug Profile


Alternative Names: Thymus nuclear protein; TNP; VGV-1

Latest Information Update: 30 Nov 2012

Price : $50

At a glance

  • Originator Viral Genetics
  • Class Antiretrovirals; Carrier proteins
  • Mechanism of Action HIV envelope protein gp41 inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 30 Nov 2012 Viral Genetics is now called VG Life Sciences
  • 15 Feb 2011 Discontinued - Clinical-Phase-Unknown for HIV infections in Bulgaria (IM)
  • 15 Feb 2011 Discontinued - Phase-III for HIV infections in South Africa (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top